CHICAGO, March 28, 2019 /PRNewswire/ — The Chartis Group, a leading provider of comprehensive advisory services and analytics to the healthcare industry, is pleased to announce that Beth Price has joined the Chartis Oncology Solutions Practice as a Director. Ms. Price brings 30 years of healthcare experience to Chartis.
Ms. Price advises healthcare clients on driving, developing and refining growth and competitive strategies, margin and cost performance improvements and helps organizations evolve their operating models. Her experience is a unique blend of serving clients across the healthcare continuum as well as a distinct focus in Oncology. Ms. Price possesses extensive experience in multiple aspects of Oncology, including financial and operating models, clinical research, cancer prevention, screening, diagnosis, treatment, navigation, survivorship and surveillance. Her Oncology expertise spans National Cancer Institute (NCI) Comprehensive Cancer Centers, Academic Medical Centers and Community/Integrated Delivery Network settings.
“Beth has dedicated her career to successfully leading healthcare organizations. Her extensive Oncology consulting and provider experience, particularly in the areas of strategic growth and margin and cost improvement, will add significantly to our capabilities,” said Greg Maddrey, President of Chartis Consulting.
Prior to joining The Chartis Group, Ms. Price served in leadership positions both in consulting and at healthcare provider organizations. She led the creation of the Sarah Cannon Research Institute for HCA and as their Chief Operating Officer, scaled the operations of the company during its initial four years. Ms. Price also served as the CEO and Executive Director of the NCI-designated Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center. Most recently, she served as a Vice President with North Highland Consulting, where she led the Nashville office.
Rhonda Mealor, Director and Practice Leader of Chartis Oncology Solutions, stated, “The Chartis Oncology Solutions Practice is thrilled to have Beth join our team. She brings a rich mix of experience from the nation’s leading cancer centers as both an executive and consultant and will complement the firm’s strong contingent of Oncology consulting leaders.”
Ms. Price holds a Master of Business Administration from Suffolk University in Boston, MA, and an undergraduate degree in health information management from Ithaca College in Ithaca, NY. She is also a Registered Health Information Management Administrator.
About The Chartis Group
The Chartis Group® (Chartis) provides comprehensive advisory services and analytics to the healthcare industry. With an unparalleled depth of expertise in strategic planning, performance excellence, informatics and technology, and health analytics, Chartis helps leading academic medical centers, integrated delivery networks, cancer centers, children’s and community hospitals and healthcare service organizations achieve transformative results. Chartis has offices in Atlanta, Boston, Chicago, New York, Minneapolis and San Francisco. For more information, visit www.chartis.com.
About Chartis Oncology Solutions
The Oncology Solutions Practice at Chartis brings over 45 years of experience working with the country’s leading academic and community cancer programs and centers. The practice offers a variety of services, including oncology service line and financial planning, strategic partnerships and affiliations, physician engagement and alignment, NCI designation gap analysis, and oncology practice optimization. Chartis Oncology Solutions offers the highest level of detailed expertise in the cancer planning field, along with our national perspective as a firm with strong enterprise planning experience, ensuring critical connections between cancer strategy and broader enterprise organizational goals are made.
View original content to download multimedia:http://www.prnewswire.com/news-releases/beth-price-joins-the-chartis-group-as-a-director-and-leader-in-the-firms-chartis-oncology-solutions-practice-300820464.html
SOURCE The Chartis Group